Liminal BioSciences Inc (Liminal BioSciences Inc (LMNL)) is up Wednesday morning, with the stock climbing 20.04% in pre-market trading to 6.65.
LMNL's short-term technical score of 6 indicates that the stock has traded less bullishly over the last month than 94% of stocks on the market. In the Biotechnology industry, which ranks 81 out of 146 industries, LMNL ranks higher than 8% of stocks.
Liminal BioSciences Inc has risen 32.85% over the past month, closing at $5.05 on January 13. During this period of time, the stock fell as low as $4.49 and as high as $5.81. LMNL has an average analyst recommendation of Sell. The company has an average price target of $13.57.
Liminal BioSciences Inc has a Long-Term Technical rank of 4. This means that trading over the last 200 trading days has placed the company in the lower half of stocks with 96% of the market scoring higher. In the Biotechnology industry which is number 54 by this metric, LMNL ranks better than 7% of stocks.
Important Dates for Investors in LMNL:
-Liminal BioSciences Inc is set to release earnings on 3/19/2021 -We do not have a set dividend date for Liminal BioSciences Inc at this time. Click Here to get the full Stock Score Report on Liminal BioSciences Inc (LMNL) Stock.